{
    "organizations": [],
    "uuid": "2c0610287c9b251e6cdfc21ec0fc06135c94ebef",
    "author": "",
    "url": "https://www.reuters.com/article/brief-myokardia-begins-patient-dosing-in/brief-myokardia-begins-patient-dosing-in-phase-1b-clinical-study-of-myk-491-idUSFWN1Q4197",
    "ord_in_thread": 0,
    "title": "BRIEF-Myokardia Begins Patient Dosing In Phase 1B Clinical Study Of Myk-491",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 52 PM / in 15 minutes BRIEF-Myokardia Begins Patient Dosing In Phase 1B Clinical Study Of Myk-491 Reuters Staff Feb 14 (Reuters) - Myokardia Inc: * MYOKARDIA BEGINS PATIENT DOSING IN PHASE 1B CLINICAL STUDY OF MYK-491 IN DILATED CARDIOMYOPATHY PATIENTS * MYOKARDIA INC - TOPLINE RESULTS FROM PHASE 1B STUDY OF MYK-491 ARE ANTICIPATED IN SECOND HALF OF 2018 Source text for Eikon:  ",
    "published": "2018-02-14T15:52:00.000+02:00",
    "crawled": "2018-02-14T16:12:47.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "begin",
        "patient",
        "dosing",
        "phase",
        "1b",
        "clinical",
        "study",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "myokardia",
        "inc",
        "myokardia",
        "begin",
        "patient",
        "dosing",
        "phase",
        "1b",
        "clinical",
        "study",
        "dilated",
        "cardiomyopathy",
        "patient",
        "myokardia",
        "inc",
        "topline",
        "result",
        "phase",
        "1b",
        "study",
        "anticipated",
        "second",
        "half",
        "source",
        "text",
        "eikon"
    ]
}